The DOI matches its Crossref record, with a small difference in title or year; 130 of the 130 references it cites were found in a registry or an index.
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Open accessAbstract
IMPORTANCE: Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a number of neurological conditions compared with healthy controls (HC) and is a candidate biomarker for neuroaxonal damage. The influence of age and sex is largely unknown, and levels across neurological disorders have not been compared systematically to date. OBJECTIVES: To assess the associations of age, sex, and diagnosis with NfL in CSF (cNfL) and to evaluate its potential in discriminating clinically similar conditions. DATA SOURCES: PubMed was searched for studies published between January 1, 2006, and January 1, 2016, reporting cNfL levels (using the search terms neurofilament light and cerebrospinal fluid) in neurological or psychiatric conditions and/or in HC. STUDY SELECTION: Studies reporting NfL levels measured in lumbar CSF using a commercially available immunoassay, as well as age and sex. DATA EXTRACTION AND SYNTHESIS: Individual-level data were requested from study authors. Generalized linear mixed-effects models were used to estimate the fixed effects of age, sex, and diagnosis on log-transformed NfL levels, with cohort of origin modeled as a random intercept. MAIN OUTCOME AND MEASURE: The cNfL levels adjusted for age and sex across diagnoses. RESULTS: Data were collected for 10 059 individuals (mean [SD] age, 59.7 [18.8] years; 54.1% female). Thirty-five diagnoses were identified, including inflammatory diseases of the central nervous system (n = 2795), dementias and predementia stages (n = 4284), parkinsonian disorders (n = 984), and HC (n = 1332). The cNfL was elevated compared with HC in a majority of neurological conditions studied. Highest levels were observed in cognitively impaired HIV-positive individuals (iHIV), amyotrophic lateral sclerosis, frontotemporal dementia (FTD), and Huntington disease. In 33.3% of diagnoses, including HC, multiple sclerosis, Alzheimer disease (AD), and Parkinson disease (PD), cNfL was higher in men than women. The cNfL increased with age in HC and a majority of neurological conditions, although the association was strongest in HC. The cNfL overlapped in most clinically similar diagnoses except for FTD and iHIV, which segregated from other dementias, and PD, which segregated from atypical parkinsonian syndromes. CONCLUSIONS AND RELEVANCE: These data support the use of cNfL as a biomarker of neuroaxonal damage and indicate that age-specific and sex-specific (and in some cases disease-specific) reference values may be needed. The cNfL has potential to assist the differentiation of FTD from AD and PD from atypical parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Self-citationMcDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Self-citationDiagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Research works printed but not linked: 2
- Vandenbroucke, 2007, 18, 805
- Tortorella, Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis [published correction appears in Mult Scler. 2019;25(2):302]., Mult Scler J
Cited by
Sorted by citations
Items 401–500 of 771
Biological and Clinical Implications of Sex-Specific Differences in Alzheimer’s Disease
Santiago, J. A., & Potashkin, J. A. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_672 · Cited by 11
Liu, C., Zhao, L., Fan, P., Ko, H., Au, C., Ng, A., Au, L. W. C., Wong, A., Kermode, A. G., Mok, V., et al. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.11.016 · Cited by 11
Fluid Biomarkers of Frontotemporal Lobar Degeneration
van der Ende, E. L., & Swieten, J. C. V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_9 · Cited by 11
Bendstrup, N., Hejl, A., & Salvesen, L. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215616 · Cited by 11
Dídac Vidal-piñeiro, A., Sørensen, Ø., Blennow, K., Capogna, E., Halaas, N. B., Idland, A., Mowinckel, A. M., Pereira, J. B., Watne, L. O., Zetterberg, H., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.04.010 · Cited by 11
Self-citationSex-Specific Diet–Microbiota Interactions in Ageing: Implications for Healthy Longevity
Hernández-Acosta, J., Tovar, A. R., & Torres, N. (2025) · Nutrients · doi:10.3390/nu17243833 · Cited by 10
White matter hyperintensity mediating gait disorders in iNPH patients via neurofilament light chain
Lu, Y., Yang, F., Deng, Y., Yan, A., Wei, W., & Fang, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1117675 · Cited by 10
Horellou, P., Flet‐Berliac, L., Leroy, C., Giorgi, L., Joly, C., Desjardins, D., Chrétien, P., Hacein‐Bey‐Abina, S., Grand, R. L., & Deiva, K. (2023) · Brain Communications · doi:10.1093/braincomms/fcad063 · Cited by 10
Associations of Neurological Biomarkers in Serum With Gait Measures: The Cardiovascular Health Study
Nadkarni, A. N., Mukamal, K. J., Zhu, X., Siscovick, D. S., Brach, J. S., Jacob, M. E., Seshadri, S. S., Abe, T., Rosano, C., Djoussé, L., et al. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae043 · Cited by 10
Duits, F. H., Nilsson, J., Zetterberg, H., Blennow, K., van der Flier, W. M., Teunissen, C. E., & Brinkmalm, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240610 · Cited by 12
Self-citationDifferences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related Diseases
Ma, J., Tang, Z., Wu, Y., Zhang, J., Wu, Z., Huang, L., Liu, S., & Wang, Y. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01523-z · Cited by 10
Zahoor, I., Sajad, M., & Giri, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073258 · Cited by 10
Braudeau, J., Souchet, B., & Streel, E. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100107 · Cited by 11
Tiraboschi, J. M., Rojas, J., Zetterberg, H., Blennow, K., Niubó, J., Gostner, J. M., Navarro-Alcaraz, A., Piatti, C. S., Fuchs, D., Gisslén, M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa645 · Cited by 10
Self-citationBlood biomarkers for HIV infection with focus on neurologic complications—A review
Hagberg, L., Edén, A., Zetterberg, H., Price, R. W., & Gisslén, M. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13629 · Cited by 10
Self-citationThe Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?
Ellen, O., Ye, S., Nheu, D., Dass, M., Pagnin, M., Öztürk, E., Theotokis, P., Grigoriadis, N., & Petratos, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311112 · Cited by 11
Verde, F., Aiello, E. N., Adobbati, L., Poletti, B., Solca, F., Tiloca, C., Sangalli, D., Maranzano, A., Muscio, C., Ratti, A., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230562 · Cited by 10
Cerebrospinal fluid protein biomarkers in Parkinson's disease
Faizan, M., Sachan, N., Verma, O., Sarkar, A., Rawat, N., & Singh, M. P. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117848 · Cited by 9
Disease Biomarkers in Multiple Sclerosis: Current Serum Neurofilament Light Chain Perspectives
Jakimovski, D., Dwyer, M. G., Bergsland, N., Weinstock‐Guttman, B., & Zivadinov, R. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2020-0058 · Cited by 10
Massa, F., Halbgebauer, S., Barba, L., Oeckl, P., José, N. G. D. S., Bauckneht, M., Lanfranchi, F., Vigo, T., Arnaldi, D., Pardini, M., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.019 · Cited by 10
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease ProgressionPreprint
Mollenhauer, B., Dakna, M., Liu, T.-Y., Galasko, D., Foroud, T., Zetterberg, H., Schade, S., Gera, R. G., Wang, W., Gao, F., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/762237 · Cited by 10
Self-citationThis was the year that was: brain barriers and brain fluid research in 2019
Keep, R. F., Jones, H. C., & Drewes, L. R. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00181-9 · Cited by 10
Torii, R., Hashizume, A., Yamada, S., Ito, D., Kishimoto, Y., Moriyoshi, H., Inagaki, T., Nakamura, R., Nakamura, T., Naoi, T., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201342 · Cited by 9
Kawarabayashi, T., Nakamura, T., Miyashita, K., Segawa, T., Fukamachi, I., Sugawara, T., Oka, H., Ishizawa, K., Amari, M., Kasahara, H., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230419 · Cited by 9
Arosio, B., Rossi, P. D., Ferri, E., Consorti, E., Ciccone, S., Lucchi, T. A., & Montano, N. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112692 · Cited by 9
Stocker, H. R., Beyer, L., Trares, K., Stevenson‐Hoare, J. O., Rujescu, D., Holleczek, B., Beyreuther, K. T., Schoettker, B., Gerwert, K. B., & Brenner, H. (2025) · Neurology · doi:10.1212/wnl.0000000000213500 · Cited by 9
Hok‐A‐Hin, Y. S., Vermunt, L., Peeters, C. F. W., van der Ende, E. L., de Boer, S. C. M., Meeter, L. H. H., Houwer, J. F. H. D., Seelaar, H., Swieten, J. C. V., Hu, W. T., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00882-5 · Cited by 19
Self-citationClinical Utility of the Pathogenesis-Related Proteins in Alzheimer’s Disease
Zhou, B., & Fukushima, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228661 · Cited by 10
Cutellé, C., Balducci, C., Cereda, D., Fusco, M. L., Iacobucci, D., Perugini, J., Pirro, F., Brivio, R., Bernasconi, D. P., Ferrarese, C., et al. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577992 · Cited by 9
Mens, H., Fjordside, L., Gynthersen, R. M. M., Ørbæk, M., Andersen, Å. B., Andréasson, U., Blennow, K., Sellebjerg, F. T., Zetterberg, H., & Lebech, A. (2023) · European Journal of Neurology · doi:10.1111/ene.15707 · Cited by 9
Self-citationvan Engelen, M. E., Heijst, H., Willemse, E. A. J., Oudega, M. L., Vermunt, L., Scheltens, P., Vijverberg, E. G. B., Pijnenburg, Y. A. L., & Teunissen, C. E. (2023) · Brain Communications · doi:10.1093/braincomms/fcad120 · Cited by 9
Self-citationHällqvist, J., Pinto, R. C., Heywood, W., Cordey, J. G., Foulkes, A., Slattery, C. F., Leckey, C. A., Murphy, E. C., Zetterberg, H., Schott, J. M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813758 · Cited by 11
Self-citationAltered plasma protein profiles in genetic FTD – a GENFI study
Ullgren, A., Öijerstedt, L., Olofsson, J., Bergström, S., Remnestål, J., Swieten, J. C. V., Jiskoot, L. C., Seelaar, H., Borroni, B., Sánchez‐Valle, R., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00677-6 · Cited by 11
Self-citationStephen, C. D., Vangel, M. G., Gupta, A. S., Macmore, J. P., & Schmahmann, J. D. (2023) · Brain Communications · doi:10.1093/braincomms/fcae019 · Cited by 9
Grønhøj, M. H., Sejbæk, T., Hansen, R. W., Larsen, L., Dahl, M., Schierbeck, J., & Poulsen, F. R. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1883730 · Cited by 9
Kessler, C., Serna-Higuita, L. M., Wilke, C., Rattay, T. W., Hengel, H., Reichbauer, J., Stransky, E., Leyva, A., Mengel, D., Synofzik, M., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51518 · Cited by 9
Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis in Real-World Settings
Perneczky, R., Hansen, N., Hofmann, A., Laske, C., Priller, J., Grimmer, T., Frölich, L., Düzel, E., Jessen, F., & Wiltfang, J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3774-6_1 · Cited by 12
Blood biomarkers in neurology: “a call to arms” for laboratory professionals
Musso, G., & Plebani, M. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0680 · Cited by 9
Is There a Value of Neurofilament Light as a Biomarker for Neurodegeneration in Parkinson's Disease?
Zetterberg, H. (2020) · Movement Disorders · doi:10.1002/mds.28101 · Cited by 9
Self-citationNeuroprotective effects of flavonoids
Taghizadieh, M., Modiri, N., Salmaninejad, A., Khayami, R., Taheri, F., Moghoofei, M., Khatami, A., Azhdari, S., Bayat, M., Samadi-khouzani, A., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824467-8.00016-4 · Cited by 8
Biofluid biomarkers for Alzheimer’s disease
Wang, S., Xie, S., Zheng, Q., Zhang, Z., Wang, T., & Zhang, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1380237 · Cited by 9
Exercise to Counteract Alzheimer’s Disease: What Do Fluid Biomarkers Say?
Bonanni, R., Cariati, I., Cifelli, P., Frank, C., Annino, G., Tancredi, V., & D’Arcangelo, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136951 · Cited by 8
Hu, Z., Cinque, P. M., Dravid, A. N., Hagberg, L., Yilmaz, A., Zetterberg, H., Fuchs, D., Gostner, J. M., Blennow, K., Spudich, S., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012470 · Cited by 10
Self-citationNeurofilament light and cognition in community-dwelling non-Hispanic Blacks
Abdullah, L. B., Zhang, F., Hall, J. R., & O’Bryant, S. E. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283693 · Cited by 9
Predictive value of serum neurofilament light chain for cognitive impairment in Parkinson’s disease
Gu, L., Zhang, P., Gao, R., Shu, H., & Wang, P. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1465016 · Cited by 8
Itorralba, J., Brand‐Arzamendi, K., Saab, G., Muccilli, A. D., & Schneider, R. (2025) · BMC Neurology · doi:10.1186/s12883-025-04145-0 · Cited by 11
Multimorbidity and fluid biomarkers of Alzheimer's disease: a systematic review
Valletta, M., Canevelli, M., Gasparini, F., Buscarnera, S., Salzillo, M., Triolo, F., Calderón‐Larrañaga, A., Marengoni, A., Vetrano, D. L., & Grande, G. (2025) · European Geriatric Medicine · doi:10.1007/s41999-025-01222-y · Cited by 8
Kivisäkk, P., Fatima, H. A., Wu, C., Padmanabhan, N., Romero, D., Gorham, T., Weik, M., Dodge, H. H., Scherzer, C. R., Das, S., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214351 · Cited by 11
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 12
Eisenstein, S. A., Boodram, R. S., Sutphen, C. L., Lugar, H. M., Gordon, B. A., Marshall, B. A., Urano, F., Fagan, A. M., & Hershey, T. G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.795317 · Cited by 8
Thermodynamic Signatures of Blood Plasma Proteome in Neurodegenerative Pathologies
Danailova, A., Todinova, S. J., Gartcheva, L., Bogdanova, D., Zlatareva, E., Kalaydzhiev, N., Milanov, I. G., Krumova, S., & Taneva, S. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010789 · Cited by 8
Jeppsson, A., Sandelius, Å., Zettergren, A., Kern, S., Skoog, I. G., Blennow, K., Zetterberg, H., Wikkelsø, C., Hellström, P., & Tullberg, M. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00455-y · Cited by 8
Self-citationNeutrophil-Mediated Progression of Mild Cognitive Impairment to Dementia
Cho, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914795 · Cited by 9
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis
Toscano, S., Oteri, V., Chisari, C. G., Finocchiaro, C., Fermo, S. L., Valentino, P., Bertolotto, A., Zappia, M., & Patti, F. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105131 · Cited by 8
Wohnrade, C., Seeliger, T., Gingele, S., Bjelica, B., Skripuletz, T., & Petri, S. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12355-8 · Cited by 8
Persistent delirium is associated with cerebrospinal fluid markers of neuronal injury
Tsui, A., Johnstone, B., Heslegrave, A., Zetterberg, H., Watne, L. O., Neerland, B. E., Krogseth, M., Cunningham, C. M., MacLullich, A. M. J., Terrera, G. M., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae319 · Cited by 7
Self-citationPham, A. T., Peterson, R., Slaughter, S., Martin, M., Hippensteel, J. A., & Burnham, E. L. (2025) · CHEST Critical Care · doi:10.1016/j.chstcc.2025.100143 · Cited by 8
Haque, M. I., Kengo, Y., Wang, J., Fischer, G., & Kirchner, J. (2021) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2021.100451 · Cited by 8
Vakrakou, A. G., Tzartos, J. S., Strataki, E., Boufidou, F., Dimou, E., Pyrgelis, E.-S., Constantinides, V. C., Paraskevas, G. P., & Kapaki, E. N. (2022) · Biomedicines · doi:10.3390/biomedicines10061262 · Cited by 8
Mens, H., Fjordside, L., Gynthersen, R. M. M., Ørbæk, M., Andersen, Å. B., Andréasson, U., Blennow, K., Sellebjerg, F. T., Zetterberg, H., & Lebech, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221098126 · Cited by 8
Self-citationMurdoch, D. M., Barfield, R., Chan, C. C. W., Towe, S. L., Bell, R. P., Volkheimer, A. D., Choe, J. E., Hall, S. A., Berger, M., Xie, J., et al. (2022) · Journal of NeuroVirology · doi:10.1007/s13365-022-01102-2 · Cited by 8
Self-citationIncreased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
Cerroni, R., Liguori, C., Stefani, A., Conti, M., Garasto, E., Pierantozzi, M., Mercuri, N. B., Bernardini, S., Fucci, G., & Massoud, R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00126 · Cited by 8
Eratne, D., Kang, M. J., Malpas, C. B., Simpson, S., Lewis, C. C., Dang, C., Grewal, J. K., Coe, A., Dobson, H., Keem, M. H., et al. (2023) · medRxiv · doi:10.1101/2023.02.19.23286151 · Cited by 8
Self-citationÖz, F., Kaya, İ., Tanır, Y., Küçükgergin, C., & Aydin, A. F. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1153 · Cited by 7
Nathoo, N., Neyal, N., Kantarci, O. H., & Zeydan, B. (2024) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2024.1412482 · Cited by 7
Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy
Ishiguro, T., & Kasuga, K. (2024) · Brain Sciences · doi:10.3390/brainsci14090859 · Cited by 7
Milà‐Alomà, M., Hulle, C. V., Brugulat‐Serrat, A., Brodu, M. M. C., González‐Escalante, A., Sánchez‐Benavides, G., Shekari, M., Castro‐Aldrete, L., Minguillón, C., Martínková, J., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01844-1 · Cited by 7
Preclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities
Palacino, F., Manganotti, P., & Benussi, A. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5040052 · Cited by 7
Yang, W., Huang, S., Xiao, H., Tao, P., & Cai, S. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1475505 · Cited by 7
Neurofilament heavy phosphorylated epitopes as biomarkers in ageing and neurodegenerative disease
Paoli, L. F. D., Kirkcaldie, M., King, A. E., & Collins, J. M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16261 · Cited by 7
Bamford, A. R., Parkin, G. M., Corey‐Bloom, J., & Thomas, E. A. (2025) · Journal of Neurology · doi:10.1007/s00415-024-12785-4 · Cited by 8
de Boer, S. C. M., Fenoglio, C., Arighi, A., Wissink, L., Riedl, L., Rue, I., Landín-Romero, R., Matis, S., Chatterton, Z., Halliday, G. M., et al. (2025) · BMJ Neurology Open · doi:10.1136/bmjno-2024-001007 · Cited by 7
Self-citationParkinson's disease fluid biomarkers for differential diagnosis of atypical parkinsonian syndromes
Yang, J., Idowu, A., Rosenthal, L. S., & Mao, X. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.150 · Cited by 7
Rao, D. B., Pardo, I. D. R., Chang, J., Bolon, B. N., & Garman, R. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-821046-8.00007-4 · Cited by 7
Abdul‐Rahman, T., Herrera‐Calderón, R. E., Ahluwalia, A., Awuah, W. A., Ferreira, T., Tan, J. K., Wolfson, M., Ghosh, S., Horbas, V. A., Garg, V., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14678 · Cited by 9
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration
Zhang, J. V., Irwin, D. J., Blennow, K., Zetterberg, H., Lee, E. B., Shaw, L. M. J., Rascovsky, K., Massimo, L. M., McMillan, C. T., Chen‐Plotkin, A. S., et al. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000959 · Cited by 7
Self-citationDiscordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes
Guo, Y., Li, H., Tan, L., Chen, S., Yang, Y., Ma, Y., Zuo, C., Dong, Q., Tan, L., Yu, J., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51196 · Cited by 7
Linnemann, C., Caviezel, M. P., Cramer, L., Melcher, T., Monsch, A. U., Kühle, J., & Leyhe, T. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100095 · Cited by 7
Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanismsPreprint
Barbour, C. R., Kosa, P. F., Varosanec, M., Greenwood, M., & Bielekova, B. (2020) · medRxiv · doi:10.1101/2020.05.18.20105932 · Cited by 7
Hazra, R., Pu, H., Foley, L. M., LITTLE-IHRIG, L. L., Hitchens, T. K., Ghosh, S., Ofori-Acquah, S. F., Hu, X., & Novelli, E. M. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad149 · Cited by 5
Xu, C., Yi, T., Qing, T., Jiang, Y., Yi, X., Xu, J., & Ma, J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1398826 · Cited by 6
Sexual dimorphisms in innate immune activation markers in predementia Alzheimer’s disease
Knudtzon, S. L., Nordengen, K., Pålhaugen, L., Gísladóttir, B., Jarholm, J. A., Bråthen, G., Skogseth, R. E., Waterloo, K. K., Selnes, P., Fladby, T., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf161 · Cited by 8
Jain, C. K., Maurya, S., & Tripathi, P. K. (2025) · Brain and Development · doi:10.1016/j.braindev.2025.104476 · Cited by 8
Araujo, I. P. Q. C., Ellingson, T. N., Schwartz, N. U., Dietz, C. D., Tammewar, G., Deniz, K., Eslami‐Amirabadi, M., Breithaupt, A. G., Rosenberg, M. F., Bui, N. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70891 · Cited by 6
Self-citationYan, S., Sahoo, A., Zerenner, T., MAREK, K. L., Sommerauer, M., Oertel, W. H., Hu, M. T., & Tofaris, G. K. (2025) · Annals of Neurology · doi:10.1002/ana.78109 · Cited by 6
Recent advances in single-molecule immunoassays and their clinical applications
Li, B., Liu, Y., Kong, L., Yin, K., Zhang, P., & Wang, X. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118604 · Cited by 6
Research advancement in fluid biomarkers for Parkinson’s disease
Gaetani, L., Paoletti, F. P., Mechelli, A., Bellomo, G., & Parnetti, L. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2403073 · Cited by 7
Neurofilament light chain plasma levels in major depressive disorder: a brief research report
Fernández-Pereira, C., Fernández-Ceballos, M. D. L. Á., Olivares, J. M., Prieto-González, J. M., & Agís‐Balboa, R. C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1476248 · Cited by 6
Olofsson, J., Bergström, S., Mravinacová, S., Kläppe, U., Öijerstedt, L., Zetterberg, H., Blennow, K., Ingre, C., Nilsson, P., & Månberg, A. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2428930 · Cited by 9
Self-citationSaracino, D., & Ber, I. L. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.007 · Cited by 7
Baumgartner, D., Mazanec, R., & Hanzalová, J. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11504-1 · Cited by 6
Alagaratnam, J., Stöhr, W., Hamlyn, E., Porter, K., Toombs, J., Heslegrave, A., Zetterberg, H., Gisslén, M., Underwood, J., Schechter, M., et al. (2024) · Journal of Virus Eradication · doi:10.1016/j.jve.2024.100381 · Cited by 6
Self-citationKulczyńska‐Przybik, A., Dulewicz, M., Doroszkiewicz, J., Borawska, R., Litman‐Zawadzka, A., Arslan, D., Kułakowska, A., Kochanowicz, J., & Mroczko, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144122 · Cited by 6
Shir, D., Mielke, M. M., Hofrenning, E. I., Lesnick, T. G., Knopman, D. S., Petersen, R. C., Jack, C. R., Algeciras‐Schimnich, A., Vemuri, P., & Graff‐Radford, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221015 · Cited by 6
Salvadó, G., Ossenkoppele, R., Ashton, N. J., Beach, T. G., Serrano, G. E., Zetterberg, H., Mattsson, N., Janelidze, S., Blennow, K., & Hansson, O. (2022) · medRxiv · doi:10.1101/2022.08.22.22279052 · Cited by 6
Self-citationGuglielmino, V., Vitali, F., Romano, Â., Primiano, G., Sciarrone, M. A., & Luigetti, M. (2025) · Neurology and Therapy · doi:10.1007/s40120-024-00696-5 · Cited by 5
Streit, S., Meinhardt, J., Gimber, N., Kestenbach, J., Siewert, C., Schmoranzer, J., Meisel, C., Ruprecht, K., Heppner, F. L., Körtvélyessy, P., et al. (2025) · Brain Pathology · doi:10.1111/bpa.70038 · Cited by 5
Coulborn, S., Roy, A. R. K., Sokołowski, A., Cryns, N. G., Lago, A. L., Cobigo, Y., Rojas, J. C., Spina, S., Grinberg, L. T., Rankin, K. P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70771 · Cited by 5
Self-citationToward Biology-Driven Diagnosis of Atypical Parkinsonian Disorders
Arias-Carrión, Ó., Romero-Gutiérrez, E., & Ortega‐Robles, E. (2025) · NeuroSci · doi:10.3390/neurosci6040107 · Cited by 5
Stable isotope labelling kinetics of neurofilament light
Leckey, C. A., Giovannucci, T. A., Coulton, J. B., He, Y., Sato, C., Ghoshal, N., Vignarajah, T., Jaunmuktane, Z., Barthélemy, N. R., Zetterberg, H., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf468 · Cited by 6
Self-citation
Metadata
- Authors
- Bridel, C., van Wieringen, W. N., Zetterberg, H., Tijms, B. M., Teunissen, C. E., and the NFL Group, Alvarez-Cermeño, J. C., Andreasson, U., Axelsson, M., Bäckström, D. C., Bartos, A., Bjerke, M., Blennow, K., Boxer, A., Brundin, L., Burman, J., Christensen, T., Fialová, L., Forsgren, L., Frederiksen, J. L., Gisslén, M., Gray, E., Gunnarsson, M., Hall, S., Hansson, O., Herbert, M. K., Jakobsson, J., Jessen-Krut, J., Janelidze, S., Johannsson, G., Jonsson, M., Kappos, L., Khademi, M., Khalil, M., Kuhle, J., Landén, M., Leinonen, V., Logroscino, G., Lu, C.-H., Lycke, J., Magdalinou, N. K., Malaspina, A., Mattsson, N., Meeter, L. H., Mehta, S. R., Modvig, S., Olsson, T., Paterson, R. W., Pérez-Santiago, J., Piehl, F., Pijnenburg, Y. A. L., Pyykkö, O. T., Ragnarsson, O., Rojas, J. C., Romme Christensen, J., Sandberg, L., Scherling, C. S., Schott, J. M., Sellebjerg, F. T., Simone, I. L., Skillbäck, T., Stilund, M., Sundström, P., Svenningsson, A., Tortelli, R., Tortorella, C., Trentini, A., Troiano, M., Turner, M. R., van Swieten, J. C., Vågberg, M., Verbeek, M. M., Villar, L. M., Visser, P. J., Wallin, A., Weiss, A., Wikkelsø, C., & Wild, E. J.
- Affiliations
- Amsterdam Neuroscience (NL)
- Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, the Netherlands
- Sahlgrenska University Hospital (SE)
- Hospital Universitario Ramón y Cajal (ES)
- Multiple Sclerosis Unit, Ramon y Cajal University Hospital, Madrid, Spain
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- University of Gothenburg (SE)
- Charles University (CZ)
- Third Faculty of Medicine, Department of Neurology, Charles University and General University Hospital, Prague, Czech Republic
- University of Antwerp (BE)
- University of California, San Francisco (US)
- Karolinska University Hospital (SE)
- Uppsala University (SE)
- Aarhus University (DK)
- Copenhagen University Hospital (DK)
- University of Oxford (GB)
- Lund University (SE)
- University of Basel (CH)
- Department of Medicine, University Hospital and University of Basel, Basel, Switzerland
- University of Eastern Finland (FI)
- China Medical University Hospital (TW)
- National Hospital for Neurology and Neurosurgery (GB)
- Queen Mary University of London (GB)
- Erasmus MC (NL)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Puerto Rico OMICS Centre, University of Puerto Rico Comprehensive Cancer Centre, San Juan
- Department of Neurology, Faculty of Medicine and Health, Orebro University Hospital, Orebro, Sweden
- Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
- Belmont University (US)
- Azienda Ospedaliera San Camillo-Forlanini (IT)
- Danderyds sjukhus (SE)
- Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card. G. Panico" (IT)
- University of Ferrara (IT)
- Alzheimer Centre and Department of Neurology, Erasmus Medical Centre, Rotterdam, the Netherlands
- Radboud University Nijmegen (NL)
- Maastricht University (NL)
- Evotec (Germany) (DE)
- Corresponding author
- Bridel, Claire
- ORCID
- Bridel, Claire
- Zetterberg, Henrik
- Tijms, Betty M.
- Teunissen, Charlotte E.
- Axelsson, Markus
- Bäckström, David C.
- Bjerke, Maria
- Blennow, Kaj
- Boxer, Adam
- Brundin, Lou
- Burman, Joachim
- Christensen, Tove
- Fialová, Lenká
- Forsgren, Lars
- Frederiksen, Jette L.
- Gisslén, Magnus
- Gray, Elizabeth
- Hall, Sara
- Hansson, Oskar
- Herbert, Megan K.
- Jakobsson, Joel
- Janelidze, Shorena
- Johannsson, Gudmundur
- Jonsson, Michael
- Kappos, Ludwig
- Khademi, Mohsen
- Khalil, Michael
- Landén, Mikael
- Leinonen, Ville
- Logroscino, Giancarlo
- Lu, Ching-Hua
- Lycke, Jan
- Malaspina, Andrea
- Mattsson, Niklas
- Meeter, Lieke H.
- Mehta, Sanjay R.
- Modvig, Signe
- Olsson, Tomas
- Paterson, Ross W.
- Piehl, Fredrik
- Pijnenburg, Yolande A. L.
- Rojas, Julio C.
- Schott, Jonathan M.
- Sellebjerg, Finn T.
- Simone, Isabella L.
- Skillbäck, Tobias
- Stilund, Morten
- Sundström, Peter
- Svenningsson, Anders
- Tortelli, Rosanna
- Tortorella, Carla
- Trentini, Alessandro
- Turner, Martin R.
- Vågberg, Mattias
- Verbeek, Marcel M.
- Villar, Luisa M.
- Visser, Pieter Jelle
- Wallin, Anders
- Weiss, Andreas
- Wikkelsø, Carsten
- Wild, Edward J.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-09-01
- Volume
- 76
- Issue
- 9
- Pages
- 1035
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC6580449
- OpenAlex
- W2950228559
- Cited by
- 764
- References
- 107
- Citations by year
- 2026: 76 · 2025: 116 · 2024: 115 · 2023: 105 · 2022: 119 · 2021: 108 · 2020: 102 · 2019: 21
- FWCI
- 65.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Eli Lilly and Company
- AstraZeneca
- Bayer
- Sanofi
- Biogen
- CHDI Foundation
- Teva Pharmaceutical Industries
- Itä-Suomen Yliopisto
- Universität Basel
- European Committee for Treatment and Research in Multiple Sclerosis
- EU Joint Programme – Neurodegenerative Disease Research
- European Federation of Pharmaceutical Industries and Associations (115372)
- European Huntington's Disease Network
- National Institute for Health and Care Research (CL-2016-18-004)
- Motor Neurone Disease Association (TURNER/OCT18/989-797, MALASPINA/APR13/817-791, MR/ K01014X/1, TURNER/OCT15/972-797)
- European Commission (HORIZON2020, 733050202, 115372, 633666)
- Bayer HealthCare
- National Research Foundation
- ZonMw (733050202, 733050822, 733050824)
- Radboud Universiteit
- Vrije Universiteit Amsterdam
- Universiteit Maastricht
- Gentofte Hospital
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (733050822)
- Karolinska Institutet
- Kuopion Yliopistollinen Sairaala
- China Medical University Hospital
- Sahlgrenska Universitetssjukhuset
- Università degli Studi di Ferrara
- China Medical University
- Red Española de Esclerosis Múltiple
- Karl-Franzens-Universität Graz
- Novo Nordisk Fonden (NNF17OC0026978)
- Medizinische Universität Graz
- Stichting Dioraphte
- Alzheimer Nederland
- H. Lundbeck A/S
- Barts Health NHS Trust
- Janssen Prevention Center
- Allergan
- University of California, San Diego
- Avid Radiopharmaceuticals
- Medical Research Council (MR/K01014X/1, MR/M008592/1)
- Economic and Social Research Council (ES/K000365/1)
- Instituto de Salud Carlos III
- National Institute on Aging (K23AG059888, P01AG019724, T32AG023481)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- neurofilament light chain, cerebrospinal fluid biomarkers, neuroaxonal damage, age and sex effects, differential diagnosis, frontotemporal dementia, HIV-associated neurocognitive disorders, amyotrophic lateral sclerosis, Huntington's disease, Alzheimer's disease, Parkinson's disease, multiple sclerosis, dementia, neuroinflammation, diagnostic accuracy, neurodegeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
